Yield10 Bioscience CEO Dr. Oliver Peoples to Present at BIO 2017

WOBURN, Mass., June 20, 2017 -- Yield10 Bioscience, Inc. (NASDAQ:YTEN) announced that CEO Oliver Peoples, Ph.D., will be presenting today at BIO 2017 on a panel entitled: Unpredictable Weather:  How biology-based ag innovations are helping society both mitigate the causes of climate change, and adapt to the impacts as they occur.  This panel is taking place from 3:00 to 4:45 pm (PT) as part of the programming for Modern Ag Innovation Day at the BIO 2017 Conference being held this week in San Diego, CA.    

As part of the panel discussion, Dr. Peoples will highlight the approach Yield10 is taking to “build better plants” by developing proprietary, breakthrough technologies to produce higher yields in major food and feed crops with lower inputs of land, water and fertilizer to enhance global food security. He will discuss ongoing research with C3003, an algal gene Yield10 is deploying as a novel yield trait for C3 photosynthetic crops including Camelina, canola, soybean and rice.  Data from recent studies suggest that C3003 may provide an entirely new strategy to improve seed yield by bringing in new metabolic functionality from non-plant systems. In addition, he will also describe the development of new traits for yield and/or drought tolerance based on genome editing approaches where the new plants have the potential to be classified as “nonregulated” and may enable the rapid commercialization of new traits in crops.  Additional confirmed panelists for the session include executives from Dupont, Intrexon, Arcadia, Syngenta and DSM North America.  Learn more about the panel at Modern Ag Unpredictable Weather Panel.  

About Yield10 Bioscience

Yield10 Bioscience, Inc. is focused on developing new technologies to achieve step-change improvements in crop yield to enhance global food security. Yield10 has an extensive track record of innovation based around optimizing the flow of carbon in living systems.  Yield10 is leveraging its technology platforms and unique knowledge base to design precise alterations to gene activity and the flow of carbon in plants to produce higher yields with lower inputs of land, water or fertilizer. Yield10 is advancing several yield traits it has developed in crops such as Camelina, canola, soybean and corn. Yield10 is headquartered in Woburn, MA and has an Oilseeds center of excellence in Saskatoon, Canada. 

For more information about the company, please visit www.yield10bio.com.

(YTEN-G)

Safe Harbor for Forward-Looking Statements  

This press release contains forward-looking statements which are made pursuant to the safe harbor provisions of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. The forward-looking statements in this release do not constitute guarantees of future performance. Investors are cautioned that statements in this press release which are not strictly historical, including, without limitation, the potential for new plants to be classified as “nonregulated” and for rapid commercialization of new traits in crops using these technologies, constitute forward-looking statements. Such forward-looking statements are subject to a number of risks and uncertainties that could cause actual results to differ materially from those anticipated, including the risks and uncertainties detailed in Yield10 Bioscience's filings with the Securities and Exchange Commission. Yield10 assumes no obligation to update any forward-looking information contained in this press release or with respect to the matters described herein.

Contacts: 
Yield10 Bioscience:
Lynne H. Brum, (617) 682-4693, [email protected]

Investor Relations Contact:  
Amato and Partners, LLC
90 Park Avenue, 17th Floor
New York, NY 10016
[email protected]